HLS:TSX, HLS Therapeutics Inc.

Why HLS stock fell on November 12

HLS Therapeutics Inc. fell 11.7% on Thursday, November 12, 2026, on 89,800 shares. The headline around the move:

HLS stock overview

HLS Therapeutics Inc. (HLS:TSX) closed at $3.71 on November 13, 2026, up 0.27% on the day. The stock trades 29.3% below its 52-week high of $5.25 and 370,900.0% above its 52-week low of $0.001. Over the past year, it lost 25.1%. HLS Therapeutics Inc. is part of the Health Care sector.

Key figures

Price
$3.71
Day change
+0.27%
Volume
172,776
Average volume
69,809
Market cap
114M+
52-week range
$0.001 – $5.25
50-day average
$4.10
200-day average
$4.29

Price action over the past year

In 252 trading sessions since November 13, 2025, HLS closed higher on 87 days (35%). Its best day was October 5, 2026 (+8.79%) and its worst was November 12, 2026 (-11.69%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 3 times.

Recent signals

HLS news

About HLS Therapeutics Inc.

HLS Therapeutics Inc, formerly Automodular Corp, is a specialty pharmaceutical company focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets.

Similar stocks

Find more stocks like HLS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.